Also, the GSP synbiotic may ameliorate NAFLD progression by downregulating the expressions of genes related to NF-κB and LPS inflammatory signaling and resolving the hepatic oxidative stress [189]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.